[Results of the functional tests using calcitonin in patients with chronic diffuse hepatopathy].
A group of ten patients suffering cirrhosis who were treated with 100 U/l of calcitonin was studied with the aim of knowing whether in patients with cirrhosis the calcitonin is able to provoke the usual characteristic biologic modifications on the basis of the knowledge of their hormonal high levels accompanied of oesteopenia. Regarding their baseline determinations, no statistically significant modifications have been observed in calcium, phosphorous, alkaline phosphatase or its thermostable and thermolabile fractions, magnesium, uric acid and creatinine plasma concentrations respectively. This absence of a biological response to calcitonin could be due either to a numeric or functional damage of the hormone receptors or a diminished biodisponibility, although there are facts suggesting a lesser hormone biopotenciality in these patients.
Lorenzo
A
A
Departamento de Medicina Interna, Hospital Provincial y Clínico, Cádiz.
López Sáez
J J
JJ
Escobar
M
M
Morán
A
A
Senra
A
A
Millán
J
J
D002116:Calcitonin / Q000494:pharmacology*; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000097:blood*; D008297:Male; D008875:Middle Aged
D002116:Calcitonin
Resultados de la prueba funcional con calcitonina en pacientes con hepatopatía crónica difusa.